2017
DOI: 10.1080/08998280.2017.11929566
|View full text |Cite
|
Sign up to set email alerts
|

Practical and Ethical Considerations in the Management of Pacemaker and Implantable Cardiac Defibrillator Devices in Terminally Ill Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2018
2018
2025
2025

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 10 publications
0
3
0
Order By: Relevance
“…Patients with capacity can refuse continued medical treatment and this includes cardiac pacemakers and defi brillators. 21 Deactivating the defi brillation function alone would allow pacing to continue but no therapeutic shocks would be delivered in the event of ventricular arrhythmia. It is important to ascertain the patient's underlying rhythm and disease process prior to deactivating a device, as this will allow an informed decision to take place.…”
Section: Patients Nearing the End Of Lifementioning
confidence: 99%
“…Patients with capacity can refuse continued medical treatment and this includes cardiac pacemakers and defi brillators. 21 Deactivating the defi brillation function alone would allow pacing to continue but no therapeutic shocks would be delivered in the event of ventricular arrhythmia. It is important to ascertain the patient's underlying rhythm and disease process prior to deactivating a device, as this will allow an informed decision to take place.…”
Section: Patients Nearing the End Of Lifementioning
confidence: 99%
“…Approximately 1.4 million people in the US (2021) ( 1 , 2 ) have implanted ICDs and ~ 50% of these require an MRI scan over the course of their lifetime ( 3 , 4 ). While most patients with implanted ICDs can have diagnostic quality MRI studies in anatomical regions distant from the heart ( 4 , 5 ), a major portion of the population that require heart studies can have severely lower quality imaging studies ( 5–7 ).…”
Section: Introductionmentioning
confidence: 99%
“…Several ethical analyses regarding ICDD have shown that it should not foster new moral issues. 9 , 10 , 11 , 12 Although withholding vs withdrawing therapies may appear to be equivalent ethically, 13 their psychological impacts may be viewed as different by some healthcare professionals and patients, 9 , 14 as shown in a qualitative patient focus group. 5 Patients viewed device deactivation as something special, 15 and this possibility was discussed with the professionals only very infrequently.…”
mentioning
confidence: 99%